MedPath

A CLINICAL TRIAL TO STUDY THE EFFECT OF THE DRUG ELATHY CHOORANAM IN PATIENTS HAVING PEPTIC ULCER

Phase 2
Conditions
Health Condition 1: K20-K31- Diseases of esophagus, stomach and duodenum
Registration Number
CTRI/2018/12/016564
Lead Sponsor
GOVERNMENT SIDDHA MEDICAL COLLEGE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

DURATION OF ILLNESS NOT MORE THAN 10 YEARS

BURNING EPIGASTRIC PAIN

ABDOMINAL BLOATING

ANOREXIA

ALTERED BOWEL HABITS

NAUSEA

VOMITING

Exclusion Criteria

PYLORIC STENOSIS

CARCINOMA STOMACH

ACUTE ABDOMINAL COLIC

GASTRIC PERFORATION

GASTRIC OBSTRUCTION

CHOLELITHIASIS

PANCREATITIS

APPENDICTIS

RENAL COLIC

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
THE OUTCOME OF THE TREATMENT IS MAINLY ASSESSED BY REDUCTION IN CLINICAL SYMPTOMS MEASURED BY ULCER INDEX SCORES BEFORE AND AFTER THE TREATMENTTimepoint: 48 DAYS
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath